{
  "id": "53ada983c09e8daf",
  "title": "U . S . FDA approves JASCAYD\u00ae ( nerandomilast ) tablets for the treatment of progressive pulmonary fibrosis in adults",
  "description": "20251219T210000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/20/tmt-newswire/globenewswire/us-fda-approves-jascayd-nerandomilast-tablets-for-the-treatment-of-progressive-pulmonary-fibrosis-in-adults/2247275",
  "published_at": "20251219T210000Z",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/20/tmt-newswire/globenewswire/us-fda-approves-jascayd-nerandomilast-tablets-for-the-treatment-of-progressive-pulmonary-fibrosis-in-adults/2247275",
    "url_mobile": "https://www.manilatimes.net/2025/12/20/tmt-newswire/globenewswire/us-fda-approves-jascayd-nerandomilast-tablets-for-the-treatment-of-progressive-pulmonary-fibrosis-in-adults/2247275/amp",
    "title": "U . S . FDA approves JASCAYD\u00ae ( nerandomilast ) tablets for the treatment of progressive pulmonary fibrosis in adults",
    "seendate": "20251219T210000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/20/875007.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}